Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs

Our study newly identifies several FDA-approved compounds that may potentially be useful in GBM treatment. Our findings provide the basis for the rational combination of statins and topoisomerase inhibitors in GBM.